SCHEMBL9501593

SCHEMBL9501593

CCOC(=O)C1=C(CC)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.85
CYP2C9 P11712 3/20 0.85
CYP3A4 P08684 3/20 0.85
ABCB11 O95342 3/20 0.85
TBXA2R P21731 3/20 0.85
ADRA1A P35348 3/20 0.85
SLC6A3 Q01959 3/20 0.85
ADORA3 P0DMS8 3/20 0.85
TSHR P16473 3/20 0.85
MEN1 O00255 2/20 0.85
CYP1A2 P05177 2/20 0.85
CYP2C19 P33261 2/20 0.85
KMT2A Q03164 2/20 0.85
HIF1A Q16665 2/20 0.85
HSD17B10 Q99714 2/20 0.85
ABCB1 P08183 2/20 0.85
ADRB3 P13945 2/20 0.85
OPRK1 P41145 2/20 0.85
SCN5A Q14524 2/20 0.85
NR1I2 O75469 2/20 0.85

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11357080 0.93 CYP2C9 (0.83) KDM4ECYP2C9CYP3A4ABCB11TBXA2R
SCHEMBL10370006 0.93 CYP2C9 (0.83) KDM4ECYP2C9CYP3A4ABCB11TBXA2R
SCHEMBL7273114 0.93 KDM4E (0.83) KDM4ECYP2C9CYP3A4ABCB11TBXA2R
(S)-Felodipine SCHEMBL29908048 0.92 CYP2C9 (1.00) KDM4ECYP2C9CYP3A4ABCB11TBXA2R
(R)-Felodipine SCHEMBL29617765 0.92 CYP2C9 (1.00) KDM4ECYP2C9CYP3A4ABCB11TBXA2R
Felodipine SCHEMBL920025 0.92 CYP2C9 (1.00) KDM4ECYP2C9CYP3A4ABCB11TBXA2R
Felodipine SCHEMBL26398 0.92 CYP2C9 (1.00) KDM4ECYP2C9CYP3A4ABCB11TBXA2R
(S)-Felodipine SCHEMBL26399 0.92 CYP2C9 (1.00) KDM4ECYP2C9CYP3A4ABCB11TBXA2R
(R)-Felodipine SCHEMBL54486 0.92 CYP2C9 (1.00) KDM4ECYP2C9CYP3A4ABCB11TBXA2R
Felodipine SCHEMBL13460298 0.92 CYP2C9 (1.00) KDM4ECYP2C9CYP3A4ABCB11TBXA2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0031801-A2 6-Substituted 4-(2',3'-dichlorophenyl)-2-methyl-1,4-dihydropyridine-3,5-dicarboxylic acid diesters having hypotensive properties as well as process for their preparation and pharmaceutical preparations containing same Aktiebolaget Hässle (SE) 1981-07-08 EP claimed
EP-0458823-B1 A PROCESS FOR PREPARATION OF ENANTIOMERICALLY PURE POLYSUBSTITUTED 1,4-DIHYDROPYRIDINES BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) 1993-10-13 EP disclosed
US-5245039-A PROCESS FOR PREPARATION OF ENANTIOMERICALLY PURE POLYSUBSTITUTED 1,4-DIHYDROPYRIDINES BOEHRINGER MANNHEIM ITALIA (IT) 1993-09-14 US disclosed
EP-0458823-A1 A PROCESS FOR PREPARATION OF ENANTIOMERICALLY PURE POLYSUBSTITUTED 1,4-DIHYDROPYRIDINES. BOEHRINGER MANNHEIM ITALIA (IT) 1991-12-04 EP disclosed
WO-1990009376-A1 A PROCESS FOR PREPARATION OF ENANTIOMERICALLY PURE POLYSUBSTITUTED 1,4-DIHYDROPYRIDINES BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) 1990-08-23 WO disclosed
EP-0383320-A1 A process for preparation of enantiomerically pure polysubstituted 1,4-dihydropyridines BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) 1990-08-22 EP disclosed
EP-0031801-A2 6-Substituted 4-(2',3'-dichlorophenyl)-2-methyl-1,4-dihydropyridine-3,5-dicarboxylic acid diesters having hypotensive properties as well as process for their preparation and pharmaceutical preparations containing same Aktiebolaget Hässle (SE) 1981-07-08 EP disclosed